Variable Rate [Domain] Variable Rate [Domain] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Reserve for excess or obsolete inventory Inventory Valuation Reserves Line of credit maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Share-based compensation arrangement by share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Loan Facility, June 30, 2025 Loan Facility, June 30, 2025 [Member] Loan Facility, June 30, 2025 Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Award Type [Domain] Award Type [Domain] Issuances Temporary Equity, Stock Issued During Period, Value, New Issues SOFR floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Research and Development Research and Development Expense, Policy [Policy Text Block] Proceeds from transaction Proceeds From Reverse Recapitalization Transaction Proceeds From Reverse Recapitalization Transaction Exit fee percentage Line Of Credit Facility, Exit Fee Percentage Line Of Credit Facility, Exit Fee Percentage Warrants issued, delayed draw commitment amount, percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Restricted stock units issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Revenue base redemption liability Revenue Base Redemption Liability Revenue Base Redemption Liability Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Fair value of warrants issued with Series B-2 preferred stock Warrants Issued In Connection With Issuance Of Preferred Stock, Value Warrants Issued In Connection With Issuance Of Preferred Stock, Value Expected share price volatility Expected volatility Measurement Input, Price Volatility [Member] Accrued liabilities - clinical trials Accrued Clinical Trial Liability, Current Accrued Clinical Trial Liability, Current Loan Facility, Initial Commitment Amount Loan Facility, Initial Commitment Amount [Member] Loan Facility, Initial Commitment Amount Payments for repurchase of warrants Payments for Repurchase of Warrants Proceeds from the issuance of common stock Proceeds from Issuance of Common Stock 24 to 36 Months Prepayment Premium Rate, Period Three [Member] Prepayment Premium Rate, Period Three Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Income Taxes Income Tax Disclosure [Text Block] SPAC Warrants SPAC Warrants [Member] SPAC Warrants Share reserve increase, percentage of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 shares at June 30, 2024 and December 31, 2023, respectively; issued and outstanding, 4,015,002 shares at June 30, 2024 and December 31, 2023, respectively. Preferred Stock, Value, Issued Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Paid-in-kind interest Debt Instrument, Paid-In-Kind Interest Percentage Debt Instrument, Paid-In-Kind Interest Percentage Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Warrants Liabilities Warrant Liability, Policy [Policy Text Block] Warrant Liability, Policy Maximum shares of common stock allowed under Purchase Agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Stock options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accrued employee benefits Accrued Employee Benefits, Current Other income (expense): Other Nonoperating Income (Expense) [Abstract] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Options, weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net loss available to common stockholders Net loss Net loss available to common stockholders Net Income (Loss) Attributable to Parent Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Leases Lessee, Operating Leases [Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] September 30, 2025 Revenue Base Redemption Feature, Period Five [Member] Revenue Base Redemption Feature, Period Five Liabilities and Stockholders’ Deficit Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Non-cash interest expense Amortization of Debt Discount (Premium) Employee Stock Employee Stock [Member] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Cost of goods sold Cost of Goods and Services Sold Share-based payment arrangement, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share-Based Compensation Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Series A Convertible Preferred Stock, floor conversion price (in dollars per share) Preferred Stock, Conversion Price, Floor Preferred Stock, Conversion Price, Floor Tranche Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Number of warrants exchanged (in shares) Class Of Warrant Or Right, Warrants Exchanged Class Of Warrant Or Right, Warrants Exchanged Patents Patents [Member] Fair value of revenue base redemption liability related to OrbiMed debt Revenue Base Redemption Feature In Connection With Debt, Value Revenue Base Redemption Feature In Connection With Debt, Value Record exchange warrants Adjustments to Additional Paid in Capital, Warrant Issued Equity Components [Axis] Equity Components [Axis] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Asset Acquisition [Domain] Asset Acquisition [Domain] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Private Placement And Working Capital Warrants Private Placement And Working Capital Warrants [Member] Private Placement And Working Capital Warrants Local Phone Number Local Phone Number Number of leases Lessee, Number Of Operating Leases Lessee, Number Of Operating Leases Accounts receivable Increase (Decrease) in Accounts Receivable Revenue base redemption liability Product Revenue Base Redemption [Member] Product Revenue Base Redemption Cash paid for interest expense Interest Paid, Capitalized, Investing Activities MedTech Acquisition Corporation MedTech Acquisition Corporation [Member] MedTech Acquisition Corporation Expenses related to business combination Payments Of Reverse Recapitalization, Transaction Costs Payments Of Reverse Recapitalization, Transaction Costs Warrants Warrant [Member] Exercises (in shares) Class Of Warrant Or Right, Warrants Exercised Class of Warrant or Right, Warrants Exercised Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants Private Warrants [Member] Private Warrants Restricted stock units Restricted Stock Units (RSUs) [Member] Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Default rate Debt Instrument, Debt Default, Rate Debt Instrument, Debt Default, Rate Debt issuance costs Debt issuance costs Payments of Debt Issuance Costs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Temporary Equity Disclosure [Abstract] Undeclared cumulative dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Number of lease renewal options exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Record issuance costs Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Accrued taxes Accrued Income Taxes, Current Payables and Accruals [Abstract] Common stock, shares authorized, standby equity purchase agreement (in shares) Common Stock, Shares Authorized, Standby Equity Purchase Agreement Common Stock, Shares Authorized, Standby Equity Purchase Agreement Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] December 31, 2025 Revenue Base Redemption Feature, Period Six [Member] Revenue Base Redemption Feature, Period Six Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Convertible preferred stock, beginning balance Convertible preferred stock, ending balance Temporary Equity, Carrying Amount, Attributable to Parent Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Interest expense Interest Expense, Debt Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Inventory, net Increase (Decrease) in Inventories Stock options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Increase in common stock reserve for future issuance (in shares) Common Stock, Period Increase (Decrease) in Capital Shares Reserved for Future Issuance Common Stock, Period Increase (Decrease) In Capital Shares Reserved For Future Issuance Award Type [Axis] Award Type [Axis] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Derivative Instruments and Hedging Activities Disclosure [Abstract] RSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Unrecognized compensation expense, RSUs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Options and RSU's outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized June 30, 2026 and thereafter Revenue Base Redemption Feature, Period Eight And Thereafter [Member] Revenue Base Redemption Feature, Period Eight And Thereafter Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Contingent earnout liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Use of Estimates Use of Estimates, Policy [Policy Text Block] Leases Lessee, Finance Leases [Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Prepaid expenses Prepaid Expense, Current Product revenue base, minimum amount required Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Revenue Base Redemption Liability Revenue Base Redemption Liability, Policy [Policy Text Block] Revenue Base Redemption Liability, Policy Amortization expense Amortization of Intangible Assets Entity Shell Company Entity Shell Company Recently Adopted Accounting Pronouncements and Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Intangible assets, net Intangible assets, net Finite-Lived Intangible Assets, Net Temporary Equity [Line Items] Temporary Equity [Line Items] Extinguishment of tranche liability Gain (Loss) on Sale of Derivatives Prepaid expenses Increase (Decrease) in Prepaid Expense Counterparty Name [Domain] Counterparty Name [Domain] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Shares issuable under the SEPA Standby Equity Purchase Agreement (SEPA) [Member] Standby Equity Purchase Agreement (SEPA) Expected term (years) Measurement Input, Expected Term [Member] Interest income Investment Income, Interest Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross profit Gross Profit Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Change in fair value of SEPA, warrant, and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Security Exchange Name Security Exchange Name Long-term debt, beginning balance Long-term debt, ending balance Long-Term Debt Proceeds from sale of common stock Sale of Stock, Consideration Received on Transaction Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR) Options to purchase common stock Share-Based Payment Arrangement, Option [Member] Contingent Earnout Liability Standby Equity Purchase Agreement Derivative Instruments and Hedging Activities Disclosure [Text Block] Share-based compensation arrangement by share-based payment award, automatic increase, percentage of total shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Unrecognized compensation expense, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Asset Acquisition [Table] Asset Acquisition [Table] Maximum Maximum [Member] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Warrant liabilities Derivative Financial Instruments, Warrant Liability [Member] Derivative Financial Instruments, Warrant Liability Restricted stock units outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Entity Address, Address Line One Entity Address, Address Line One Exchange ratio (in shares) Recapitalization Exchange Ratio Recapitalization Exchange Ratio Dynavax Purchase Asset Acquisition [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Proceeds from MTAC trust account Proceeds from Contributed Capital Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Current stock price Stock price Measurement Input, Share Price [Member] December 31, 2024 Revenue Base Redemption Feature, Period Two [Member] Revenue Base Redemption Feature, Period Two Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Net Transfer In (Out) of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Subsequent Event Subsequent Event [Member] Restricted cash (included in Other assets) Restricted Cash, Noncurrent Other current liabilities Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Trade payables and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization Proceeds from sale of common stock (in shares) Issuances (in shares) Stock Issued During Period, Shares, New Issues Title of 12(b) Security Title of 12(b) Security Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Warrants and Rights Note Disclosure [Abstract] Share reserve increase, number of years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Asset Acquisition [Line Items] Asset Acquisition [Line Items] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Deemed dividend Preferred Stock, Convertible, Down Round Feature, Increase (Decrease) in Equity, Amount Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Automatic conversion, anniversary Preferred Stock, Automatic Conversion, Period Preferred Stock, Automatic Conversion, Period Income Tax Disclosure [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Inventory Inventory Inventory, Net Proceeds from private placement Proceeds from Issuance of Private Placement Westminster Facility Westminster Facility [Member] Westminster Facility Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Warrant holder support for Warrant Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Supplemental disclosures of cash flow information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Inventory Disclosure [Abstract] Revenue base redemption feature, amount Revenue base redemption liability Revenue Base Redemption Feature, Amount Revenue Base Redemption Feature, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] SEPA derivative liability Standby Equity Purchase Agreement (SEPA) Derivative Liability [Member] Standby Equity Purchase Agreement (SEPA) Derivative Liability Standby Equity Purchase Agreement Derivatives, Policy [Policy Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Warrant liability Warrant liability Warrant Liability Warrant Liability Transaction costs incurred Reverse Recapitalization, Transaction Costs Incurred Reverse Recapitalization, Transaction Costs Incurred Common stock, shares outstanding (in shares) Balances, beginning of period (in shares) Balances, end of period (in shares) Common Stock, Shares, Outstanding Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Summary of Components of Inventory Schedule of Inventory, Current [Table Text Block] Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Debt Instrument [Axis] Debt Instrument [Axis] Warrant and SEPA liabilities Derivative Liability, Noncurrent Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Measurement Input Type [Domain] Measurement Input Type [Domain] Total liabilities Liabilities Asset Acquisition [Axis] Asset Acquisition [Axis] Deemed dividend related to Series B-2 preferred stock down round provision Preferred Stock, Convertible, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount Change in Unrealized (Gains) Losses Equity, Fair Value Disclosure, Unrealized Gain (Loss) Equity, Fair Value Disclosure, Unrealized Gain (Loss) Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period Class of Warrant or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Accrued bonus Accrued Bonuses, Current Plan Name [Axis] Plan Name [Axis] Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Derivative liability, measurement input Warrant Liability, Measurement Input Warrant Liability, Measurement Input Earnings Per Share [Abstract] Earnings Per Share [Abstract] Purchase agreement period Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Sales and marketing Selling and Marketing Expense Common stock, $0.0001 par value per share. Authorized 400,000,000 shares at June 30, 2024 and December 31, 2023, respectively; issued and outstanding, 27,159,463 and 26,413,213 shares at June 30, 2024, and December 31, 2023, respectively. Common Stock, Value, Issued Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Expected draws Measurement Input, Expected Draws [Member] Measurement Input, Expected Draws General and administrative General and Administrative Expense Warrants repurchased (in shares) Class Of Warrant Or Right, Number Of Warrants Repurchased Class Of Warrant Or Right, Number Of Warrants Repurchased Organization, Consolidation and Presentation of Financial Statements [Abstract] Reduction in the carrying amount of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Total current assets Assets, Current Preferred stock Preferred Stock [Member] Payments on finance lease liabilities Finance Lease, Principal Payments Number of equity incentive plans Number of Equity Incentive Plans Number of Equity Incentive Plans Other expense, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Conversion price, second automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Statement [Table] Statement [Table] Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Trade payables Accounts Payable, Trade, Current Estimated dividend yield Dividend yield Measurement Input, Expected Dividend Rate [Member] SEPA derivative liability Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Warrants outstanding (in shares) Warrants outstanding, beginning balance (in shares) Warrants outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Working capital warrants Working Capital Warrants Working Capital Warrants [Member] Working Capital Warrants Proceeds from the issuance of preferred stock Proceeds from Issuance of Preferred Stock and Preference Stock Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized RSU weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Share-based compensation arrangement by share-based payment award, automatic increase, percentage of initial share reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Value of shares purchased in ESPP offering Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Class of Stock [Axis] Class of Stock [Axis] Initial OrbiMed Warrant liability Initial OrbiMed Warrant OrbiMed Warrants [Member] OrbiMed Warrants Accrued liabilities Other Accrued Liabilities, Current Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Administrative fee Debt Instrument, Fee Amount Accrued payroll Accrued Salaries, Current Transfer of warrant liability to preferred stock upon exercise of warrants Class of Warrant or Right, Transfer of Warrant to Preferred Stock Class of Warrant or Right, Transfer of Warrant to Preferred Stock Nature of Business Nature of Operations [Text Block] Initial OrbiMed Warrant Initial OrbiMed Warrant [Member] Initial OrbiMed Warrant Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Number of lease renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Lease Contractual Term [Domain] Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Entity Information [Line Items] Entity Information [Line Items] Proceeds from exercise of preferred stock warrants Proceeds from Warrant Exercises Business Combination and Asset Acquisition [Abstract] Total stockholders’ deficit Balance, beginning of period Balance, end of period Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] June 30, 2025 Revenue Base Redemption Feature, Period Four [Member] Revenue Base Redemption Feature, Period Four Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Purchases of intellectual property and licenses Payments to Acquire Intangible Assets Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock exchange for warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Level 2 Fair Value, Inputs, Level 2 [Member] Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Entity Emerging Growth Company Entity Emerging Growth Company Finished goods Inventory, Finished Goods, Gross Exchange Warrants (Equity-Classified) Exchange Warrants (Equity-Classified) [Member] Exchange Warrants (Equity-Classified) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Stock converted, reverse recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Antidilutive Securities [Axis] Antidilutive Securities [Axis] Standby equity purchase agreement, maximum allowable percentage of outstanding common stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Issuances (Settlements) Equity, Fair Value Disclosure, Issuances (Settlements) Equity, Fair Value Disclosure, Issuances (Settlements) PIK interest PIK interest Paid-in-Kind Interest Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Common stock, $0.0001 par value Common stock Common Stock [Member] Bannockburn Facility Bannockburn Facility [Member] Bannockburn Facility Proceeds from the issuance of preferred stock Proceeds from Issuance of Convertible Preferred Stock Change in fair value of Initial OrbiMed Warrants and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net Loss Per Share Earnings Per Share [Text Block] Share-based compensation arrangement by share-based payment award, automatic increase period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Summary of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Tranche Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Public Warrants, Private Placement Warrants And Working Capital Warrants Public Warrants, Private Placement Warrants And Working Capital Warrants [Member] Public Warrants, Private Placement Warrants And Working Capital Warrants Accrued vacation Accrued Vacation, Current Minimum Minimum [Member] Property and equipment, net Property, Plant and Equipment, Net Business Combination Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Exercise price Measurement Input, Exercise Price [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Change in Unrealized (Gains) Losses Unrealized loss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Total liabilities and stockholders’ deficit Liabilities and Equity Other assets Other Assets, Noncurrent Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Right-of-use assets Operating Lease, Right-of-Use Asset Equity, Fair Value Disclosure [Roll Forward] Equity, Fair Value Disclosure [Roll Forward] Equity, Fair Value Disclosure Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Sale of Stock [Domain] Sale of Stock [Domain] Warrants, term Earnout shares vesting requirement, vesting period Warrants and Rights Outstanding, Term Warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Entity Address, City or Town Entity Address, City or Town Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Deposits Increase (Decrease) in Deposits Outstanding Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Fair value of warrants issued with OrbiMed debt Warrants Issued In Connection With Debt, Value Warrants Issued In Connection With Debt, Value Document Transition Report Document Transition Report September 30, 2024 Revenue Base Redemption Feature, Period One [Member] Revenue Base Redemption Feature, Period One 12 to 24 Months Prepayment Premium Rate, Period Two [Member] Prepayment Premium Rate, Period Two Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Expected draws Derivative liability, measurement input Derivative Liability, Measurement Input Raw materials Inventory, Raw Materials, Gross Document Information [Table] Document Information [Table] Paid in kind interest, term Debt Instrument, Paid-In-Kind Interest, Term Debt Instrument, Paid-In-Kind Interest, Term Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Issuances (in shares) Class Of Warrant Or Right, Shares Issued During Period Class Of Warrant Or Right, Shares Issued During Period Liability Class [Axis] Liability Class [Axis] March 31, 2026 Revenue Base Redemption Feature, Period Seven [Member] Revenue Base Redemption Feature, Period Seven Measurement Input Type [Axis] Measurement Input Type [Axis] Within 12 Months Prepayment Premium Rate, Period One [Member] Prepayment Premium Rate, Period One Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity Cranston Facility Cranston Facility [Member] Cranston Facility Additional paid-in capital Additional Paid in Capital Debt instrument, prepayment premium rate Debt Instrument, Prepayment Premium Rate Debt Instrument, Prepayment Premium Rate Derivative instrument, contingent consideration, liability, earnout period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Derivative Instrument, Contingent Consideration, Liability, Earnout Period After 48 Months Prepayment Premium Rate, Period Five [Member] Prepayment Premium Rate, Period Five Subsequent Event Type [Axis] Subsequent Event Type [Axis] Proceeds from the exercise of stock options for common stock Proceeds from Stock Options Exercised Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Shares unvested (in shares) Contingent Consideration, Liability, Shares Number of Shares Unvested 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Purchase agreement, ownership limitation Class Of Warrant Or Right, Ownership Limitation Class Of Warrant Or Right, Ownership Limitation Series B-3 warrant liabilities Derivative Financial Instruments, Series B-3 Warrant Liability [Member] Derivative Financial Instruments, Series B-3 Warrant Liability Convertible notes and warrants Convertible Notes and Warrants [Member] Convertible Notes and Warrants Closing price (in dollars per share) Share Price 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Schedule of Convertible Preferred Stock Temporary Equity [Table Text Block] Retirements/Conversions (in shares) Class of Warrant Or Right, Conversion Of Convertible Securities Class of Warrant Or Right, Conversion Of Convertible Securities Entity Registrant Name Entity Registrant Name March 31, 2025 Revenue Base Redemption Feature, Period Three [Member] Revenue Base Redemption Feature, Period Three 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Outstanding warrant liabilities Warrants and Rights Outstanding Loss on equity issuance Loss on equity issuance Gain (Loss) on Equity Issuance Gain (Loss) on Equity Issuance Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Lease Contractual Term [Axis] Lease Contractual Term [Axis] Public Warrants Public Warrants [Member] Public Warrants Document Period End Date Document Period End Date Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Convertible Preferred Stock Preferred Stock [Text Block] Entity Central Index Key Entity Central Index Key Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Change in fair value of warrants and SEPA liability Change in fair value of warrants and SEPA liability Derivative, Gain (Loss) on Derivative, Net Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Income tax expense Income tax expense Income Tax Expense (Benefit) Transaction costs paid from proceeds Reverse Recapitalization, Transaction Costs Paid Reverse Recapitalization, Transaction Costs Paid Financial Instruments Fair Value Disclosures [Text Block] Preferred stock warrants Preferred Stock Warrant [Member] Preferred Stock Warrant Loan Facility Loan Facility [Member] Loan Facility Cash and Cash Equivalents [Abstract] Tranche One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Proceeds from sale of common stock Issuance of stock Stock Issued During Period, Value, New Issues Stockholders’ deficit: Equity [Abstract] Inventory Inventory Disclosure [Text Block] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Undeclared dividends on Series A preferred stock Preferred Stock Dividends, Income Statement Impact Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Intangible Assets Intangible Assets Disclosure [Text Block] Number of trading days, VWAP Preferred Stock, Number of Trading Days, Volume Weighted Average Price Preferred Stock, Number of Trading Days, Volume Weighted Average Price 2023 Plan 2023 Plan [Member] 2023 Plan 36 to 48 Months Prepayment Premium Rate, Period Four [Member] Prepayment Premium Rate, Period Four Commercial Milestone Commercial Milestone [Member] Commercial Milestone Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Shares purchased in ESPP offering (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Conversion price, first automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Contingent Earnout Liability Business Combinations Policy [Policy Text Block] Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Long-term debt, net of unamortized discount and debt issuance costs Long-Term Debt, Excluding Current Maturities Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Reverse Recapitalization [Abstract] Reverse Recapitalization Additional number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Operating expenses: Operating Expenses [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid-in Capital [Member] Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Total assets Assets Beginning balance Ending balance Equity, Fair Value Disclosure Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amortization of debt issuance costs Amortization of Debt Issuance Costs Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type Rent payments Lessee, Operating Lease, Liability, to be Paid Upfront payment Asset Acquisition, Consideration Transferred Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Tranche Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three Secured Debt Secured Debt [Member] Lease renewal term Lessee, Operating Lease, Renewal Term Equity Component [Domain] Equity Component [Domain] Stock options exercise price, percentage of fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Expected probability of draws Measurement Input, Expected Probably of Draws [Member] Measurement Input, Expected Probably of Draws Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period Proceeds from business combination Proceeds From Reverse Recapitalization Proceeds From Reverse Recapitalization Undrawn fee, percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Statement [Line Items] Statement [Line Items] Accretion of exit fee liability Accretion Expense Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Series B-2 tranche liabilities Derivative Financial Instruments, Tranche Liability [Member] Derivative Financial Instruments, Tranche Liability Proceeds from the issuance of debt Proceeds from lines of credit Proceeds from Long-Term Lines of Credit Warrants Warrants Liabilities [Text Block] Warrants Liabilities Loan Facility, December 31, 2025 Loan Facility, December 31, 2025 [Member] Loan Facility, December 31, 2025